ClassID:

94733

C07D273/02 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups  -  having two nitrogen atoms and only one oxygen atom

Sub-classes:
Recent Application in this class:
#1
20250171408
2025-05-29

NOVEL SOLID STATE FORMS OF INDOXACARB

#2
20240207224
2024-06-27

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

#3
20240092731
2024-03-21

CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF

#4
20230009671
2023-01-12

AI assisted cyclic carbonate monomer synthesis

#5
20220227703
2022-07-21

Creatine prodrugs, compositions and methods of use thereof

#6
20210249714
2021-08-12

Lithium Air Secondary Battery

#7
20210002211
2021-01-07

Creatine prodrugs, compositions and methods of use thereof

#8
20200255416
2020-08-13

BAF complex modulating compounds and methods of using the same

#9
20190248755
2019-08-15

Crystal form of ozanimod hydrochloride and processes for preparation therefor

#10
20180369268
2018-12-27

METHODS FOR IDENTIFYING INHIBITORS OF "STIMULATOR OF INTERFERON GENE"- DEPENDENT INTERFERON PRODUCTION

#11
20180127328
2018-05-10

THERMAL PRE-IGNITION AGENT

#12
20170340758
2017-11-30

PET probes of radiofluorinated carboximidamides for IDO-targeted imaging

#13
20170334838
2017-11-23

Process for the preparation of raltegravir

#14
20170166569
2017-06-15

Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto

#15
20170066753
2017-03-09

Oxadiazine compounds and methods of use thereof

#16
20160347790
2016-12-01

Synthesis of syrbactin proteasome inhibitors

#17
20160251324
2016-09-01

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#18
20160190467
2016-06-30

Amine-based compound and organic light-emitting device including the same

#19
20160046590
2016-02-18

SONIC HEDGEHOG MODULATORS

#20
20160024033
2016-01-28

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#21
20150246907
2015-09-03

PYRIDOMYCIN BASED COMPOUNDS EXHIBITING AN ANTITUBERCULAR ACTIVITY

#22
20150148313
2015-05-28

Macrocyclic factor VIIa inhibitors

#23
20150051183
2015-02-19

Conformationally constrained, fully synthetic macrocyclic compounds

#24
20140345192
2014-11-27

Methods for reducing heavy oil viscosity

#25
20140206760
2014-07-24

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#26
20140135339
2014-05-15

Macrocyclic derivatives for the treatment of diseases

#27
20140039011
2014-02-06

Macrocyclic urea and sulfamide derivatives as inhibitors of tafia

#28
20130196965
2013-08-01

Cyclic amides

#29
20130065872
2013-03-14

Synthesis of syrbactin proteasome inhibitors

#30
20120108499
2012-05-03

PEPTOID COMPOUNDS

#31
20110312875
2011-12-22

Peptidic compounds

#32
20110245243
2011-10-06

Compounds and compositions as cathepsin S inhibitors

#33
20110237595
2011-09-29

DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS

#34
20110178130
2011-07-21

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#35
20110059940
2011-03-10

2-Aryl Glycinamide Derivatives

#36
20110034353
2011-02-10

Method of preparing a nanoparticulate iron—crown ether complex

#37
20100291199
2010-11-18

Compositions and Methods For The Treatment and Prevention of Disease

#38
20100240708
2010-09-23

Alpha-(N-benzenesulfonamido)cycloalkyl derivatives

#39
20100167995
2010-07-01

PEPTOID COMPOUNDS

#40
20100113504
2010-05-06

AMIDE COMPOUNDS AND THEIR USE AS ANTITUMOR AGENTS

#41
20100069405
2010-03-18

DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS

#42
20100063013
2010-03-11

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

#43
20090312370
2009-12-17

MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS

#44
20090281139
2009-11-12

MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

#45
20090253908
2009-10-08

NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS

#46
20090170878
2009-07-02

MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS

#47
20090069288
2009-03-12

Novel therapeutic compounds

#48
20080300287
2008-12-04

Peptidic compounds

#49
20080214526
2008-09-04

Macrocyclic compounds and compositions useful as BACE inhibitors

#50
20080194691
2008-08-14

Macrocyclic inhibitors of BCL proteins

#51
20080194535
2008-08-14

Diaminopropane derived macrocycles as inhibitors of β amyloid production

#52
20080132477
2008-06-05

Macrocyclic Compounds Useful as Bace Inhibitors

#53
20080070885
2008-03-20

MACROCYCLIC COMPOUNDS HAVING ASPARTIC PROTEASE INHIBITING ACTIVITY AND PHARMACEUTICAL USES THEREOF

#54
20080033167
2008-02-07

Compositions and methods for synthesizing heterocyclic therapeutic compounds

#55
20080031951
2008-02-07

Compositions and methods for the inhibition of phospholipase A2

#56
20070293469
2007-12-20

Compositions and methods for the treatment and prevention of disease

#57
20070232606
2007-10-04

Compounds and compositions as cathepsin S inhibitors

#58
20070208054
2007-09-06

Macrocyclic factor VIIa inhibitors useful as anticoagulants

#59
20070111927
2007-05-17

Peptoid compounds

#60
20070021426
2007-01-25

Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors

#61
20060223745
2006-10-05

Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof

#62
20060058278
2006-03-16

Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's disease

#63
20060040910
2006-02-23

Macrocycles useful in the treatment of alzheimer's disease

#64
20060009443
2006-01-12

Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists

#65
20060003978
2006-01-05

Macrocycles useful in the treatment of alzheimer's disease

#66
20050043509
2005-02-24

Peptoid compounds

#67
15628476
2018-01-02

Dihydropyrimidinone derivatives